dianhydro-3,4-diacetylgalactitol has been researched along with Cystadenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grönroos, M; Kangas, L; Mäenpää, J; Paul, R; Vanharanta, R | 1 |
1 other study(ies) available for dianhydro-3,4-diacetylgalactitol and Cystadenocarcinoma
Article | Year |
---|---|
Steroid receptors and response of ovarian cancer to cytostatic drugs in vitro.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Cisplatin; Cystadenocarcinoma; Dianhydrogalactitol; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |